These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2459982)

  • 1. [The interferon-natural killer cell system of patients with ovarian tumors].
    Sorokin AM; Moiseeva NB; Cheredeev AN; Frolova IS
    Akush Ginekol (Mosk); 1988 May; (5):23-7. PubMed ID: 2459982
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The interferon system and natural cytotoxicity functions in patients with acute viral hepatitis A and B].
    Kaverina OV; Chernova LG; Fabrikov AP; Malinovskaia VV; Kasimova NB; Karpenko SF; Sluvko EI; Cherenova OP
    Ter Arkh; 1994; 66(2):7-9. PubMed ID: 7512755
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural killer (NK) cell activity in the peripheral blood of patients with malignant diseases: melanoma, carcinoma, chronic and acute lymphatic leukemia].
    Gabrilovac J
    Lijec Vjesn; 1985 Aug; 107(8):323-6. PubMed ID: 3864002
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating serum interferon and its effect on human natural killer cell activity].
    Cheknev SB; Ashmanova IaG; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Dec; 118(12):619-22. PubMed ID: 7535580
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic possibilities of virus-modified tumor cell extracts and interleukin-2 in human ovarian cancer.
    Lotzová E
    Nat Immun Cell Growth Regul; 1986; 5(6):277-82. PubMed ID: 3491956
    [No Abstract]   [Full Text] [Related]  

  • 9. Human leukocyte interferon therapy for advanced ovarian carcinoma.
    Einhorn N; Cantell K; Einhorn S; Strander H
    Am J Clin Oncol; 1982 Apr; 5(2):167-72. PubMed ID: 6178284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro changes in natural killer cell activity in draining lymph nodes of oral carcinomas].
    Vinzenz K; Strassl H; Micksche M
    Dtsch Z Mund Kiefer Gesichtschir; 1984; 8(6):421-7. PubMed ID: 6085294
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.
    Siew YY; Neo SY; Yew HC; Lim SW; Ng YC; Lew SM; Seetoh WG; Seow SV; Koh HL
    Int Immunol; 2015 Dec; 27(12):621-32. PubMed ID: 26138671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
    Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interferon levels and natural killer cell activity in patients with asbestosis.
    Kagamimori S; Watanabe M; Kubota M; Okada A; Yokoyama K; Nobutomo K
    Thorax; 1984 Jan; 39(1):65-6. PubMed ID: 6198742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of natural killer (NK) cells].
    Abo T
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():189-92. PubMed ID: 9097586
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methodological approaches to early detection of benign epithelial tumors of the ovaries].
    Alikhanova ZM
    Akush Ginekol (Mosk); 1992 Jan; (1):9-14. PubMed ID: 1621923
    [No Abstract]   [Full Text] [Related]  

  • 16. [Human natural killer activity in selected test systems and tissue compartments: natural killer cell modulation by biological response modifiers].
    Klappacher G
    Wien Klin Wochenschr; 1988 Nov; 100(22):743-6. PubMed ID: 3149079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of natural killer cytotoxicity during childhood: marked increases in number of natural killer cells with adequate cytotoxic abilities during infancy to early childhood.
    Yabuhara A; Kawai H; Komiyama A
    Pediatr Res; 1990 Oct; 28(4):316-22. PubMed ID: 1700360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon.
    Seaman WE; Merigan TC; Talal N
    J Immunol; 1979 Dec; 123(6):2903-5. PubMed ID: 227961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
    Cancer Res; 1985 Sep; 45(9):4447-53. PubMed ID: 4028027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suitability of a clinical practice method of evaluating the activity of natural and antibody-dependent killer cells].
    Gordienko SM
    Lab Delo; 1983; (9):45-8. PubMed ID: 6195439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.